Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

Prescribing information for Fiasp®▼ (insulin aspart) can be found here
Prescribing information for Tresiba® (insulin degludec) can be found here

In association with

Small changes can make a big difference to Time in Range:

Exploring the role of technology and modern insulins for improving glycaemic control in diabetes

This promotional meeting is organised and funded by Novo Nordisk and Abbott.
Marketing and organisational support has been provided by OmniaMed Communications.
The information presented at this meeting is for UK-based healthcare professionals only.
Adverse event reporting information and prescribing information will be available at this meeting.
© 2021 Novo Nordisk and Abbott.

Prescribing information for Fiasp®▼ (insulin aspart) can be found here

Prescribing information for Tresiba® (insulin degludec) can be found here

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes.

Job code: UK21DI00341, ADC-43965 V1.0 | Date of preparation: September 2021

Thank you for registering.

We look forward to welcoming you online. You will receive a confirmation email shortly and we will send you a reminder email closer to the start of the virtual conference.

You are leaving this site.

You are now leaving https://live.diabetesonthenet.com/register.
Links to external website are provided as a resource to the viewer.
This website is neither owned nor controlled by Novo Nordisk or Abbott. Novo Nordisk and Abbott accept no responsibility for the content or services of the linked site.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.